Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.

Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013 Jan 15; 158(2):84-92.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.